Tag: Boston
Mass General Brigham vs. Dana-Farber: Hospital Battle Unveiled
A battle is brewing behind the scenes in the world of healthcare, as the future of cancer care hangs in the balance. The clash between two prominent Massachusetts health care giants, Mass General Brigham...
Biogen CEO Plans to Acquire Biotechs: Expect Deals Ahead
Biogen CEO Eyes Biotech Acquisitions: Anticipate Major Deals in 2025SAN FRANCISCO — Chris Viehbacher, the CEO of Biogen, revealed his company's ambitious plans to acquire more biotechs in 2025. In an exclusive interview before...
Top Predictions from Four Digital Health Unicorns for 2025
Leaders of Digital Health Unicorns Reflect on 2024 and Predictions for 2025In the fast-paced world of digital health, 2024 was a year of significant growth and success for some of the industry's biggest players....
Advancing RNA-Based Drugs in Rare Diseases: Sarepta and Arrowhead Pharmaceuticals Partnership
Sarepta Therapeutics has announced a significant partnership with Arrowhead Pharmaceuticals to develop RNA-based drugs for rare diseases. The deal includes a $500 million cash payment from Sarepta to Arrowhead, along with a $325 million...
Biotech Analyst and CEO Discuss Election Results: Insights from Brian Skorney and Daphne Zohar
Biotech analyst Brian Skorney and biotech executive Daphne Zohar recently appeared on "The Readout LOUD" podcast to share their thoughts on how the outcomes of the recent election may impact the biotech industry. They...
